 LIPC Fundraising Plan (2025–2030)

Life International Pharmaceutical Company – Uganda


---

1. Purpose of the Fundraising Plan

The purpose of this fundraising plan is to secure the capital required to develop and operationalize the Life International Pharmaceutical Company (LIPC), a world-class research, medical water, scientific training, and pharmaceutical production facility serving East and Central Africa.

The total project cost is $167 million, divided into land acquisition + project phases.


---

2. Total Funding Requirements

A. Land Acquisition (Separate)

1 square mile of land

Cost: $25 million


B. Total Project Construction Cost

$142 million
(This excludes land purchase)


C. Grand Total Project Budget

$167 million
($25M land + $142M facility development)



---

3. Fundraising Goals by Phase

Phase 1 Goal (2025–2026)

Target: $35 million (excluding land)
Breakdown:

Initial laboratories & cleanrooms: $20M

Administrative & operational setup: $7M

Permits, legal, compliance: $3M

Initial utilities & engineering: $5M


Phase 2 Goal (2026–2027)

Target: $60 million
Includes:

Full pharmaceutical production lines

Medical water production (D5, D10, Normal Saline)

Mechanical, civil & electrical works

Advanced R&D facilities


Phase 3 Goal (2027–2030)

Target: $47 million
Includes:

Hospital development

National training center for scientists

Expanded manufacturing capacity

Distribution & logistics center



---

4. Fundraising Strategy

A. International Donor Agencies (Target: $40M)

USAID

Global Fund

WHO & UNIDO

African Development Bank

Bill & Melinda Gates Foundation

Wellcome Trust


B. Philanthropic Foundations (Target: $30M)

MacArthur Foundation

Rockefeller Foundation

Open Society Foundations


C. Private & Institutional Investors (Target: $50M)

Healthcare venture capital firms

Pharmaceutical impact investors

African business leaders

Diaspora investment groups


D. Government Partnerships (Target: $20M)

Ministry of Health

Ministry of Science & Technology

National Medical Stores (procurement partnerships)


E. Corporate CSR Partnerships (Target: $10M)

MTN, Airtel

Stanbic, Absa, Equity Bank

Energy corporations


F. Public Fundraising Campaigns (Target: $5–10M)

GoFundMe

GlobalGiving

LIPC official website

Social media donor drives



---

5. Annual Fundraising Targets

2025 Target

$20 million

Major donors, foundations, and public campaigns.


2026 Target

$30 million
Focus on grants and private investors.

2027–2030 Target

$92 million
For large-scale infrastructure and hospital construction.


---

6. Donor Engagement Strategy

A. Donor Tiers

Bronze Partner: $10,000 – $100,000

Silver Partner: $100,000 – $1,000,000

Gold Partner: $1 million – $10 million

Platinum Partner: $10 million+

Benefits include recognition, naming rights, and partnership roles.


B. Outreach Tools

LIPC pitch deck (15 slides)

Corporate profile (PDF)

Website fundraising section

Donor newsletter

Social media fundraising drives


C. Communication Plan

Monthly updates

Quarterly progress reports

Annual impact report

Donor appreciation events



---

7. Risk Management

A. Funding Gaps

Mitigation: Diversify donors across 6 categories.

B. Delayed Grant Payments

Mitigation: Maintain rolling fundraising cycles.

C. Economic Instability / Inflation

Mitigation: Hold capital in USD and lock contract prices early.

D. Regulatory Delays

Mitigation: Early engagement with government agencies.


---

8. Monitoring & Evaluation

Key performance indicators (KPIs):

Quarterly funds raised

Donor retention rate

Number of new partners

Grant approval success rate

Project construction progress vs budget


A centralized dashboard will track all metrics.


---

9. Project Leadership

Dr. Katabazi Abdallah (PhD) — Founder & Executive Director

Dr. Musoke Moses (PhD) — CEO

Eng. Matovu Paul — CEO (Engineering & Infrastructure Development)

Dr. Muyomba Allan — Head of Research

Dr. Namukasa Saidah — Research Lead

Eng. Mukasa Ismail — Director of Electrical Systems



---

10. Conclusion

This fundraising plan provides a structured, diversified, and scalable path to raising $167 million for the development of LIPC — an advanced pharmaceutical, research, and medical production facility that will significantly transform healthcare outcomes across East and Central Africa.

LIPC will become a regional hub for:
✔ essential medicine production
✔ medical water manufacturing
✔ scientific research
✔ advanced laboratory services
✔ training African scientists
